Zanganeh Maky's Form 4 filing
Summit Therapeutics Inc. (SMMT) · filed Dec 13, 2023
- Accession no.
- 0001599298-23-000103
- Filed
- Dec 13, 2023
- Trade date
- Dec 11-12, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $10.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zanganeh MakyCIK 0001507650 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2023 | Common Stock | XIn-the-money exerciseAcquired | +489,814 | $1.44 | +$705,332.16 | 489,814 | Direct | |
| Dec 12, 2023 | Common Stock | PPurchaseAcquired | +5,000 | $2.07 | +$10,350 | 494,814 | Direct | |
| Dec 11, 2023 | Common Stock | XIn-the-money exerciseAcquired | +315,681 | $1.58 | +$498,775.98 | 24,889,479 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2023 | Common Stock | XIn-the-money exerciseDisposed | −489,814 | $0.00 | $0 | 0 | Direct | |
| Dec 11, 2023 | Common Stock | XIn-the-money exerciseDisposed | −315,681 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.